関連する実験動画
Updated: Jan 9, 2026
01:27
Pulmonary Embolism III: Nursing Management
Published on: June 19, 2025
320
まとめ
研究者らは,Saccharomyces cerevisiaeのキチン合成酵素の生成に不可欠なCHS1遺伝子を特定しました. この酵素は細胞壁の完全性にとって不可欠であり,その遺伝子はクローン化され,特徴づけられました.
科学分野:
- 分子生物学は分子生物学である.
- イースト遺伝学 イースト遺伝学
背景:
- チチン合成酵素は,Saccharomyces cerevisiaeのプラズマ膜に結合したジモゲンである.
- 活性化キチン合成酵素は不溶性キチンを合成し,芽の傷跡に含まれるキチンに似ています.
研究 の 目的:
- チチン合成酵素をコードするCHS1遺伝子をクローンして特徴づけること.
- 分裂酵母を用いたキチン合成酵素の構造遺伝子としてCHS1を確認する.
主な方法:
- チチン合成酵素欠乏変異体の分離 (chs1).
- CHS1遺伝子のクローニング.
- S. pombe.におけるCHS1-lacZ融合タンパク質の発現
- CHSIの遺伝子破壊実験について.
主要な成果:
- CHS1遺伝子は3400塩基の開いた読み取り枠を持ち,130kdのタンパク質をコードする.
- S. pombeにおけるCHS1-lacZの発現はキチン合成酵素の活性を与え,CHS1の役割を確認した.
- CHSI遺伝子の障害は, in vitro チチン合成酵素の活性が失われ,生存能力と正常な in vivo チチン濃度が維持された.
結論:
- CHS1は,S. cerevisiaeのキチン合成酵素の構造遺伝子である.
- CHS1の障害はキチン合成酵素の活性に影響しますが,細胞の生存能力や重要な機能には影響しません.
関連する概念動画
01:27Pulmonary Embolism III: Nursing Management
320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
01:29Pulmonary Embolism I: Introduction
464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
01:29Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
01:27Pneumothorax-II
852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
852
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K